Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.68%
SPX
-1.02%
IXIC
-1.34%
FTSE
-0.70%
N225
-0.68%
AXJO
-0.58%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Key Stats

Market Cap
22.05M
Dividend Yield
0.00%
P/E Ratio
-2.27
EPS
-0.72
Revenue
-
Avg. Volume
72.67K

Recently from Cashu

publisher logo
Cashu

Why NanoViricides (NNVC) Could Be a $6 Stock — And Why Investors Are Starting to Notice

5 days ago
publisher logo
Cashu

The Tiny Biotech Aiming to Disrupt the $80 Billion Antiviral Market: Why NanoViricides (NNVC) Deserves a Closer Look

13 days ago
publisher logo
Cashu

Could This Tiny Biotech Be the Key to Stopping a Measles Comeback?

18 days ago

About

What does NNVC do?
NanoViricides, based in Shelton, Connecticut, develops nanomedicine drugs targeting enveloped viruses, with lead candidates NV-CoV-2 for COVID-19 and NV-HHV-1 for Shingles. The company went public on August 12, 2004.
Sector
💻 Health Care
IPO
August 12, 2024
CEO
Dr. Anil R. Diwan
Employees
7
Headquarters
Connecticut, USA
Website
http://www.nanoviricides.com
Join our newsletter to keep up to date with us!
Stocks
Health Care
nnvc
NanoViricides
NNVC
+0.10 (+0.00%)
1.41
USD
At close at May 19, 13:26 UTC
Summary
News
Videos
Signals
Benchmarks
Financials